Page 37 - உயிரி தொழில்நுட்பவியல் நிறுவனம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GAITHERSBURG, Md., Feb. 16, 2021 (GLOBE NEWSWIRE) Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced it will report its fourth quarter 2020 financial results and operational highlights following the close of U.S. financial markets on Monday, March 1, 2021. Conference call details are as follows:Date:Time:Dial-in number:Passcode:Webcast:March 1, 20214:30 p.m. U.S. Eastern Time (ET)(877) 212-6076 (Domestic) or (707) 287-9331 (International)3797013www.novavax.com/events Conference call and webcast replay:Date:Dial-in number:Passcode:Webcast:Starting at 7:30 p.m. ET, March 1, 2021(855) 859-2056 (Domestic) or (404) 537-3406 (International)3797013www.novavax.com/events, until June 1, 2021 About Novavax Novavax, Inc. (Nasdaq: NVAX) is a biotechnology company that promotes improved health globally through the discovery, development and commercialization of innovative vaccines to prevent serious infectious

Infectious diseasesBiotechnology companyFinancial resultsதொற்று நோய்கள்உயிரி தொழில்நுட்பவியல் நிறுவனம்நிதி முடிவுகள்